Jun Sun, PhD, MS, AGAF
Professor of Medicine, University of Illinois at Chicago College of Medicine
Dr. Sun’s research interests are host-microbiome interactions in inflammation and cancer. She currently serves as the AGA Institute Council Microbiome & Microbial Therapy (MMT) section chair and co-chair of the AGA Institute Council Basic Science Subcommittee. As MMT section chair, Dr. Sun also sits as an ex officio member of the AGA Center for Gut Microbiome scientific advisory board, and she has published over 200 scientific articles.
Why GI Doctors Care About Neurodegenerative Diseases: Target Gut-Neuron-Microbiome for Novel Treatments
“Aberrant Enteric Neuromuscular System and Dysbiosis in Amyotrophic Lateral Sclerosis”
- Microbiome in Gastrointestinal and Liver Diseases
- Functional GI and Motility Disorders
- Education and Training
Date and Time:
Monday, May 23, 2–3:30 p.m. PDT
Register to Attend
Altered intestinal homeostasis and microbiome contribute to a variety of neurological diseases, such as Alzheimer’s disease and Parkinson’s disease. This session will cover the impact of the microbiome on gut-neuron-axis in CNS and ENS. Dr. Sun’s presentation will focus on the microbiome and Amyotrophic Lateral Sclerosis (ALS). ALS is not very well understood, and gastrointestinal symptoms in ALS patients before their diagnosis are often ignored. Dr. Sun’s lab did the pioneer work in identifying the intestinal inflammation and dysfunction of microbiome in patients with ALS.
After attending this presentation, participants will learn the research progress and understand the potential for these studies to help us develop more accurate diagnosis and better treatment, not only for ALS, but also for other neurogenerative diseases.